Extracorporeal Magnetotransduction Therapy (EMTT) is a non-invasive treatment solution that opens up new possibilities in regeneration and rehabilitation. The areas of application include chronic diseases of the musculoskeletal system such as lower back pain, arthrosis (osteoarthritis), or inflammation of the tendons...
Extracorporeal Magnetotransduction Therapy (EMTT) differs from other general forms of magnetic field therapy or PEMF (pulsed electromagnetic field therapy) in its higher oscillation frequency (100 – 300 kHz) and magnetic field strength (> 10 mT), resulting in a strong »effective transduction...
During Extracorporeal Magnetotransduction Therapy (EMTT), painful areas of the body are treated with high-energy magnetic pulses, the field strength of which lies within the therapeutically effective range – 10 mT (millitesla) and upward. With this pulse intensity, it is possible to...
Extracorporeal Magnetotransduction Therapy (EMTT) can cause a positive cell modulation. Every cell undergoes chemical reactions that serve to generate energy. The prerequisite for this is membrane permeability. A stable cell membrane ensures permeability for vital substances. A pathological change leads to...
Disorders of the musculoskeletal system are the most common cause of (chronic) pain around the globe. These disorders include back pain and osteoarthritis as well as typical sports injuries such as inflammation of the tendons and joints. Extracorporeal Magnetotransduction Therapy (EMTT)...
EMTT treatment with the MAGNETOLITH® requires little effort, is non-invasive and practically free from side effects. For patients, the treatment is comfortable and straightforward: The therapy loop is positioned over the area of pain while the patient remains fully clothed – direct...
The MAGNETOLITH® system is a joy to work with. It features a modern design and is extremely easy to use. The powerful applicator ensures optimum transmission of the therapeutically effective magnetic field to the patient. Its effective cooling system enables interruption-free...
Placebo-controlled studies published in 2017 & 2018 show the huge potential of EMTT – both as a stand-alone therapy and as a supplement to focused shock wave therapy (ESWT). While ESWT uses high energy acoustic effects on a local treatment area,...
In our little series on Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH® we have talked a lot about the advantages of the new therapy option. But what do the experts say who are already working with EMTT? What is their verdict?...
We continue our series on Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH® with another user’s opinion. This time from Michael Strøm, Denmark: »During the last six months, I have successfully conducted around 950 EMTT treatments with the MAGNETOLITH® within a wide...
Prof Dr Karsten Knobloch from Hannover, Germany, is also among the convinced users of Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH®. »For me, MAGNETOLITH® complements the combined shock wave therapy in a congenial way. In my sports practice, I see clear...
It is time to wrap up our little series on Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH® – STORZ MEDICAL’s new touch-free solution for the treatment of chronic diseases of the musculoskeletal system. To conclude this series, we would like to...
